Showing results (1-10 of 655) with videos related to
Sort By:
Pageof 66
Clinical Microbiology Reviews|January 18, 2005
Aspergillus infections in transplant recipientsNina Singh, David L PatersonTransplantation|January 28, 2003
Lack of efficacy of mupirocin in the prevention of infections with Staphylococcus aureus in liver transplant recipients and candidatesDavid L Paterson, John D Rihs, Cheryl Squier, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 9, 2008
Impact of antibiotic resistance in gram-negative bacilli on empirical and definitive antibiotic therapyDavid L PatersonClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 2, 2026
Advancing Clinical Evidence in Infectious Diseases: An Infectious Diseases Clinical Trials Network for Asia, the "Antimicrobial Resistance Hot Zone"David L PatersonSeminars in Respiratory Infections|December 24, 2002
Serious infections caused by enteric gram-negative bacilli--mechanisms of antibiotic resistance and implications for therapy of gram-negative sepsis in the transplanted patientDavid L PatersonCritical Care Medicine|January 25, 2003
Restrictive antibiotic policies are appropriate in intensive care unitsDavid L PatersonClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 9, 2006
The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter speciesDavid L PatersonClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 6, 2004
"Collateral damage" from cephalosporin or quinolone antibiotic therapyDavid L PatersonClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 16, 2005
The role of antimicrobial management programs in optimizing antibiotic prescribing within hospitalsDavid L PatersonThe Medical Journal of Australia|March 19, 2013
Determining research priorities for clinician-initiated trials in infectious diseasesDavid L Paterson, Pageof 66